Bloomios (Bloomios) Dividend Payout Ratio : 0.00 (As of Sep. 2023)

View and export this data going back to 2003. Start your Free Trial

What is Bloomios Dividend Payout Ratio?

Bloomios's dividend payout ratio for the months ended in Sep. 2023 was 0.00.

The historical rank and industry rank for Bloomios's Dividend Payout Ratio or its related term are showing as below:

BLMS's Dividend Payout Ratio is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 0.33
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2024-06-22), the Dividend Yield % of Bloomios is 0.00%.

Bloomios's Dividends per Share for the months ended in Sep. 2023 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Bloomios Dividend Payout Ratio Historical Data

The historical data trend for Bloomios's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bloomios Dividend Payout Ratio Chart

Bloomios Annual Data

Trend

Jun02

Jun03

Jun04

Jan05

Jan06

Jan07

Jan19

Jan20

Dec21

Dec22

Dividend Payout Ratio

Get a 7-Day Free Trial

Bloomios Quarterly Data
	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Dividend Payout Ratio	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Bloomios's Dividend Payout Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Bloomios's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bloomios's Dividend Payout Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bloomios's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Bloomios's Dividend Payout Ratio falls into.

Bloomios Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Bloomios's Dividend Payout Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Dec. 2022 )	/	EPS without NRI (A: Dec. 2022 )
	=	0	/	-0.939
	=	N/A

Bloomios's Dividend Payout Ratio for the quarter that ended in Sep. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Sep. 2023 )	/	EPS without NRI (Q: Sep. 2023 )
	=	0	/	-0.023
	=	N/A

Bloomios (OTCPK:BLMS) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Bloomios Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Bloomios's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Bloomios (Bloomios) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bloomios Inc (OTCPK:BLMS) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

701 Anacapa Street, Suite C, Santa Barbara, CA, USA, 93101

Website

https://www.bloomios.com

Bloomios Inc manufactures, markets, and distributes U.S. hemp-derived supplements and cosmetic products through wholesale distribution channels in the United States of America. It offers its private-label and white-label customers large collections of customizable hemp products that include over 80 products across 7 categories in addition to custom formulation and manufacturing services. Its product categories include edibles, tinctures, oils, salves, capsules, balms, lotions, creams, beverages, and pet treats.

Executives

Douglas S Rohrer	officer: Chief Business Officer	701 ANACAPA, SUITE C, SANTA BARBARA CA 93101
Emc2 Capital Llc	10 percent owner	201 W MONTECITO STREET, SANTA BARBARA CA 93101
Barrett Evans	director, 10 percent owner, officer: Pres, Chief Strategy Officer
Aline Hayuta Elkayam	10 percent owner	104 CHELSEA PLACE, ORMOND BEACH FL 32174
Bibi Daprile	10 percent owner	12 WINDING CREEK WAY, ORMOND BEACH FL 32174
Agpl Acquisition, Inc	10 percent owner	201 W MONTECITO ST., SANTA BARBARA CA 93101
Mammoth Crest Capital Llc	10 percent owner	1712 PIONEER AVE, SUITE 558, CHEYENNE WY 82001
Michael Hill	director, 10 percent owner, officer: Chief Executive Officer	201 WEST MONTECITO STREET, SANTA BARBARA CA 93101
Bryan Glass	director, 10 percent owner, officer: President and Director	20 WEST PARK AVENUE, SUITE 207, LONG BEACH NY 11561
Douglas Boyd	director, officer: Chairman of the Board	8101 TIARA COVE CIR, LAS VEGAS NV 89128
Peter A Hogendoorn	director, officer: President & CEO	13288 AMBLE GREEN PLACE, SURREY A1 V4A 6P5
Harold C Moll	director, 10 percent owner
Van Laare Derek R	officer: Secretary	6119 GORDON AVENUE, BURNABY A1 V5E 3M2
Carlo Civelli	other: former director/officer/owner	111 SOMERSET ROAD, TRIPLE ONE SOMERSET 06-06, SINGAPORE U0 238164
Logan Anderson	director, officer: President & Treasurer	15 HILL CRESCENT, PEMBROKE BERMUDA D8 00000